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Definition
The term cardiomyopathy refers to a diffuse or gener-
alized myocardial disorder of unknown cause, Patients who
meet this criterion have idiopathic or primary involvement
of the myocardium. Secondary myocardial diseases result-
ing from metabolic, nutritional, endocrine or ischemic causes
are excluded, However, it is quite possible for valvular,
hypertensive or coronary artery disease to coexist with pri-
mary cardiomyopathy,
Classification
Using a pathophysiologic classification based on the
dominant type of ventricular dysfunction, there are three
broad types described, although overlap among the types
may be observed.
1) Dilated or congestive cardiomyopathy. Primary
characteristics are impaired systolic function with dilation
of chambers and increased muscle mass without complete
compensatory increase in wall thickness. In some cases
dilation may be minimal or absent.
2) Hypertrophic cardiomyopathy. This is character-
ized by normal or small chamber size, increased wall thick-
ness, hyperdynamic systolic ejection and impaired diastolic
filIing characteristics,
3) Restrictive or infiltrative cardiomyopathy. The
myocardium shows increased stiffness secondary to infil-
trative morphologic abnormalities that lead to diastolic dys-
function. The atria are dilated and systolic function is im-
paired in late stages.
Myocardial Function and Aging
The effects of aging on myocardial function are not well
defined in humans, There is some evidence of diastolic
dysfunction, although systolic function and cavity dimen-
sions are unaffected (I). Studies in animals support some
reductions in diastolic function with aging. The intrinsic
heart rate (that is, after removal of autonomic influence on
the sinoatrial pacemaker) is reduced. A diminished inotropic
response to catecholamines has been reported (2), as has a
©1987 by the American College of Cardiology
decrease in ventricular response to hemodynamic stress dur-
ing beta-adrenergic blockade (3).
The effects ofaging on the myocardium appear to include
diastolic dysfunction, reduced responsiveness to catechol-
amines and slowing of the intrinsic heart rate. These, alone,
are not sufficient to result in clinical evidence of cardiac
dysfunction. However, they may play an additive role in
elderly patients with systolic hypertension, mild degener-
ative valvular disease, anemia or other concomitant disor-
ders.
Dilated Congestive Cardiomyopathy
This condition is thought to be uncommon in the elderly,
although approximately 10% of patients in large series are
>65 years (4-8). It is possible that the published reports
are biased in favor of younger patients, Congestive heart
failure is often erroneously attributed to ischemic heart dis-
ease or hypertension. Alternatively, the reported age dis-
tribution represents a selection process such that few people
with dilated cardiomyopathy survive beyond age 65.
Diagnosis. The diagnosis is generally confirmed by
echocardiographic evidence of four chamber dilation with
depressed ventricular systolic function. The diagnosis of
dilated cardiomyopathy further rests on the exclusion of
etiologic factors that can result in diffuse myocardial systolic
dysfunction. Important among the factors to be excluded
are adriamycin toxicity, postirradiation damage and chronic
alcoholism. Although alcoholic cardiomyopathy is some-
times considered a secondary myocardial disease charac-
terized by dilated cardiomyopathy, the myocardial depres-
sant effects of alcohol excess may precipitate or exacerbate
heart failure in patients with idiopathic dilated cardio-
myopathy. Dilated cardiomyopathy may also be misdi-
agnosed as heart failure secondary to coronary artery dis-
ease. Angiography should be considered in patients who are
thought to have dilated cardiomyopathy who have chest
pain. There is a propensity for thrombus formation and
subsequent systemic embolic events with dilated cardio-
myopathies; this should be considered as a cause of stroke
or transient ischemic attacks in the elderly.
0735-1097/87/$3.50
78A SHAH ET AL.
CARDIOMYOPATHY
JACC Vol. 10, No.2
August 1987:77A-79A
Treatment. Treatment is essentially that of heart failure
due to systolic dysfunction and anticoagulation. Digitalis is
especially useful in the presence of atrial fibrillation or other
supraventricular tachyarrhythmias. Caution is advised in
prescribing vasodilator drugs, because excessive hypoten-
sion may prove hazardous.
Acutemyocarditis. Acute myocarditis appears to be rare
in the elderly and is difficult to diagnose clinically, although
an acute onset with a short history is suggestive. The com-
mon etiologic agents are viruses, particularly Coxsackie-
virus, and rickettsia. Endomyocardial biopsy can demon-
strate conspicuous cellular infiltrates with cellular degeneration
and necrosis. The role of endomyocardial biopsy both in
diagnosis and as a guide to therapy, particularly in the el-
derly, is not known.
Immunosuppressive therapy has been proposed to treat
subacute and chronic myocarditis diagnosed by biopsy.
However, the diagnostic criteria are uncertain and thera-
peutic efficacy remains to be determined. Furthermore, im-
munosuppressive agents may be poorly tolerated in the el-
derly (9).
Hypertrophic Cardiomyopathy
Although early reports suggested that this condition was
rare in older patients, patients beyond the seventh decade
are included in many large series (10-12). Widespread use
of echocardiography may uncover more patients with hy-
pertrophic cardiomyopathy with few or no symptoms.
Symptoms. Symptoms in older patients are similar to
those in younger subjects; these include dizziness, syncope,
dyspnea, chest pain and palpitation. A correct diagnosis is
often delayed in the elderly because dizziness and syncope
may be attributed to cerebrovascular causes, chest pain to
coronary artery disease and dyspnea to associated lung dis-
ease. This may explain why the diagnosis of hypertrophic
cardiomyopathy was considered in only a third of patients
hefore referral for evaluation (II).
Physical findings. Patients with left ventricular outflow
"obstruction" with intraventricular pressure gradients may
have characteristic physical findings: bifid carotid pulse,
double apical impulse, a fourth heart sound and a systolic
murmur that increases with the Valsalva maneuver and de-
creases with squatting. Aortic regurgitation due to coexist-
ing aortic valve calcification occurs in some elderly patients
with hypertrophic "obstructive" cardiomyopathy and should
not exclude this diagnosis. Coexisting mitral anulus calci-
fication with mitral regurgitation may mask the diagnosis
of hypertrophic cardiomyopathy.
Sudden death. Most natural history studies of hyper-
trophic cardiomyopathy have emphasized the rarity of sud-
den death in elderly patients with this condition (13). This
may represent survival of a subgroup with a low propensity
to sudden arrhythmic death. Alternatively, less vigorous
physical activity in the aged may be protective.
Pathology. The morphologic features of hypertrophic
cardiomyopathy in the elderly are similar to those in younger
patients (14), but hypertrophy is often more pronounced and
may be concentric with severe free wall hypertrophy equal
to that of the septum. Fibrous endocardial thickening of the
upper interventricular septum and of the anterior mitral leaf-
let is common. Associated abnormalities in the elderly in-
clude mitral anulus calcification and degenerative calcific
aortic valve disease. More extensive valvular calcification
may result in the coexistence of valvular and myocardial
disease. An awareness of such coexistence is necessary for
the correct diagnosis and management of hypertrophic car-
diomyopathy in the elderly.
Echocardiography. Unsuspected hypertrophic cardio-
myopathy may be detected by echocardiography obtained
for other indications because the classical physical signs are
often absent or masked, or the diagnosis is not considered.
The typical combination of echocardiographic findings in-
cludes asymmetric left ventricular hypertrophy, hyperdy-
namic left ventricular function, systolic anterior motion of
the anterior mitral valve leaflet and left atrial enlargement.
Doppler ultrasound evidence of an impaired diastolic filling
rate and an intraventricular pressure gradient increase the
diagnostic accuracy. Usually echocardiography is the only
diagnostic test necessary.
Treatment. The therapy of the elderly patient with hy-
pertrophic cardiomyopathy is similar to that of the young
patient (15,16). Asymptomatic patients without high grade
arrhythmias require no treatment. Symptomatic patients are
usually managed with beta-receptor blocking agents; cal-
cium channel blockers are also useful, although these drugs
have increased adverse effects in the elderly, such as, con-
stipation, ankle edema and hypotension. These adverse
effects may be accentuated by surgery or vasodilator or di-
uretic drug therapy. Surgery, namely myotomy and myec-
tomy, may be indicated in symptomatic patients with a
demonstrable outflow gradient in whom medical therapy has
failed. The surgical approach often results in gratifying
symptomatic improvement with an acceptably low operative
mortality rate (17,18). Endocarditis prophylaxis is war-
ranted for appropriate surgical procedures.
Hypertensive hypertrophic cardiomyopathy of the el-
derly. Topol et al. (19) recently described elderly patients
with the syndrome of "hypertensive hypertrophic cardio-
myopathy of the elderly." All patients had a history of
hypertension; chest pain or dyspnea was the presenting com-
plaint in the majority. Echocardiographically, the syndrome
was characterized by severe concentric cardiac hypertrophy,
a small left ventricular cavity and supernormal indexes of
ventricular systolic function. Systolic anterior motion of the
mitral valve and cavity obliteration were noted in many
patients. Impaired left ventricular diastolic function as man-
ifested by a prolonged early diastolic filling period and a





reduced rate of diastolic filling appears to be the most likely
cause of the presenting symptoms of pulmonary congestion.
Congestive heart failure with normal systolic function may
similarly be due to hypertrophic cardiomyopathy or early
stages of restrictive cardiomyopathy (20,21). This syndrome
is not distinct from hypertrophic cardiomyopathy except for
concentric hypertrophy and associated hypertension. It may
be seen at any age, but appears to be more frequently rec-
ognized in the elderly.
Restrictive Cardiomyopathy
Amyloidosis. Primary amyloidosis is a frequent cause
of restrictive cardiomyopathy, but is not common in the
elderly. The characteristic features of this condition include
small ventricles and large atria with elevated filling pressures
and thickened walls; a characteristic "sparkling" of the
ventricular myocardium on the echocardiogram; the ECG
may show low QRS voltage, atrial fibrillation and conduc-
tion defects. Diagnostic confirmation can be obtained by
biopsy of rectal, gingival or endomyocardial tissue. There
is no specific treatment.
Senile cardiac amyloidosis is a separate pathologic entity
seen after 70 years of age. Its prevalence increases with
age, reaching nearly 80% in those >95 years of age (22).
The macroscopic appearance is often normal. Microscopi-
cally, the earliest amyloid deposits are seen in atrial cap-
illaries. In advanced cases, small deposits may be present
in the valves. Conducting tissue is affected late, if at all. It
is unclear if senile amyloidosis has any functional clinical
significance, although atrial fibrillation may coexist with
larger atrial deposits.
Irradiation. A restrictive type of physiology may oc-
casionally result from irradiation damage. This may be clin-
ically evident months or years after the radiation therapy.
Postoperative pericarditis. An increasing number of
patients in this age group are likely to develop postoperative
restrictive cardiomyopathy, presumably secondary to post-
coronary artery bypass graft or other surgical pericarditis.
Summary
Cardiomyopathies in the elderly have certain character-
istic features. The dilated form appears to be less common
than in younger patients. Hypertrophic cardiomyopathy is
more often associated with severe and concentric hypertro-
phy (14). The prognosis of hypertrophic cardiomyopathy
seems to be better in the elderly, because they appear to
have a lower incidence of sudden death. Restrictive cardio-
myopathies are not common in the elderly, and senile amy-
loid heart disease rarely, if ever, results in congestive heart
failure. A syndrome of clinical heart failure with reduced
diastolic compliance and preserved systolic function is more
common in elderly patients.
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